Abstract
Background Plasma exchange is an effective therapy for myasthenic crisis (MC); yet the number of exchanges needed is unknown. We set out to examine the relationship between the number of plasma exchanges and clinical outcome in patients experiencing MC.
Methods We retrospectively reviewed patient episodes with ICD 9 and ICD 10 codes for myasthenia gravis and myasthenia gravis exacerbation/crisis in patients admitted to a single center tertiary care referral center from July 2008 to July 2017. These episodes were screened for patients with impending myasthenia gravis crisis and manifest crisis who received plasmapheresis during their hospital course. We performed statistical analyses to determine if increased number of plasma exchanges improves the primary outcome (hospital length of stay), as well as the secondary outcome (disposition to home, skilled nursing facility, long term acute care hospital, or death).
Results There is neither clinically observable nor statistically significant improvement in length of stay or disposition on discharge in patients who received six or greater sessions of plasmapheresis.
Conclusions This study provides class IV evidence that extending the number of plasma exchanges beyond five does not correlate with decreased hospital length of stay or improved discharge disposition in patients experiencing myasthenic crisis.
- Myasthenia Gravis
- Myasthenic Crisis
- Plasmapheresis
- Plasma Exchange
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veteran Affairs and the Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland OH. LN is also supported by the VA Parkinson Disease Research, Education and Clinical Centers (PADRECC).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board and Ethics Committee of University Hospitals Cleveland Medical Center gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Statistical analysis performed by Michael Hansen and Melanie Parikh.
Lee Neilson neilsole{at}ohsu.edu
Melanie Parikh mxp496{at}case.edu
Bashar Katirji bashar.katirji{at}uhhospitals.org
Funding: This work was supported by the Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veteran Affairs and the Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland OH. LN is also supported by the VA Parkinson’s Disease Research, Education and Clinical Centers (PADRECC).
Authors financial relationships relevant to manuscript:
Dr. Hansen reports no disclosures.
Dr. Neilson reports no disclosures.
Dr. Parikh reports no disclosures.
Dr. Katirji receives honoraria for published medical textbooks from Springer, Oxford University Press, and Elsevier.
Data Availability
Raw data will be shared if requested.
